The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks
Abstract
Precise gene editing is—or will soon be—in clinical use for several diseases, and more applications are under development. The programmable nuclease Cas9, directed by a single-guide RNA (sgRNA), can introduce double-strand breaks (DSBs) in target sites of genomic DNA, which constitutes the initial step of gene editing using this novel technology. In mammals, two pathways dominate the repair of the DSBs—nonhomologous end joining (NHEJ) and homology-directed repair (HDR)—and the outcome of gene editing mainly depends on the choice between these two repair pathways. Although HDR is attractive for its high fidelity, the choice of repair pathway is biased in a biological context. Mammalian cells preferentially employ NHEJ over HDR through several mechanisms: NHEJ is active throughout the cell cycle, whereas HDR is restricted to S/G2 phases; NHEJ is faster than HDR; and NHEJ suppresses the HDR process. This suggests that definitive control of outcome of the programmed DNA lesioning could be achieved through manipulating the choice of cellular repair pathway. In this review, we summarize the DSB repair pathways, the mechanisms involved in choice selection based on DNA resection, and make progress in the research investigating strategies that favor Cas9-mediated HDR based on the manipulation of repair pathway choice to increase the frequency of HDR in mammalian cells. The remaining problems in improving HDR efficiency are also discussed. This review should facilitate the development of CRISPR/Cas9 technology to achieve more precise gene editing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In CRISPR-gene editing, HDR requires a large amount of donor (exogenous) DNA templates containing a sequence of interest.
“In CRISPR-gene editing, HDR requires a large amount of donor (exogenous) DNA templates containing a sequence of interest.”
From Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing (2021) · cites this paper as [17]
HDR is most active in the late S and G2 phases of the cell cycle.
“It is most active in the late S and G2 phases of the cell cycle.”
From Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing (2021) · cites this paper as [17]
HDR executes the precise gene insertion or replacement by adding a donor DNA template with sequence homology at the predicted DSB site.
“HDR executes the precise gene insertion or replacement by adding a donor DNA template with sequence homology at the predicted DSB site.16,17”
From Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing (2021) · cites this paper as [17]
HDR is highly precise and requires the use of a homologous DNA template.
“HDR is highly precise and requires the use of a homologous DNA template.”
From Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing (2021) · cites this paper as [17]
NHEJ is an error-prone mechanism that may result in small random insertion or deletion (indels) at the cleavage site leading to the generation of frameshift mutation or premature stop codon.
“It is the predominant and efficient cellular repair mechanism that is most active in the cells, but it is an error-prone mechanism that may result in small random insertion or deletion (indels) at the cleavage site leading to the generation of frameshift mutation or premature stop codon.17”
From Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing (2021) · cites this paper as [17]
NHEJ is the predominant and efficient cellular repair mechanism that is most active in the cells.
“It is the predominant and efficient cellular repair mechanism that is most active in the cells, but it is an error-prone mechanism that may result in small random insertion or deletion (indels) at the cleavage site leading to the generation of frameshift mutation or premature stop codon.17”
From Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing (2021) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway
Lieber, M. R. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.052308.093131 · Cited by 2,882
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
Maruyama, T., Dougan, S. K., Truttmann, M. C., Bilate, A. M., Ingram, J. R., & Ploegh, H. L. (2015) · Nature Biotechnology · doi:10.1038/nbt.3190 · Cited by 1,137
The promise and challenge of therapeutic genome editing
Doudna, J. A. (2020) · Nature · doi:10.1038/s41586-020-1978-5 · Cited by 1,126 · cited 1×
“Precise genomic editing based on programming nucleases is opening up the possibility of achieving desired genome editing outcome in vitro and in vivo, and ensure its safe and rapid adoption for genome engineering applications across biology [1,2].”
BackgroundRegulation of Homologous Recombination in Eukaryotes
Heyer, W.-D., Ehmsen, K. T., & Liu, J. (2010) · Annual Review of Genetics · doi:10.1146/annurev-genet-051710-150955 · Cited by 1,066
Regulation of DNA repair pathway choice in S and G2 phases by the NHEJ inhibitor CYREN
Arnoult, N., Correia, A., Ma, J., Merlo, A., Garcia-Gomez, S., Maric, M., Tognetti, M., Benner, C. W., Boulton, S. J., Saghatelian, A., et al. (2017) · Nature · doi:10.1038/nature24023 · Cited by 299
Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer.
Sulli, G., Di Micco, R., & di Fagagna, F. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3344 · Cited by 238
Flagged first, then by citations
Research works printed but not linked: 123
- WareJoncas, 2018, Precision gene editing technology and applications in nephrology, Nat. Rev. Nephrol., 14, 663, 10.1038/s41581-018-0047-x · DOI
- Cox, 2015, Therapeutic genome editing: Prospects and challenges, Nat. Med., 21, 121, 10.1038/nm.3793 · DOI · Paper page
- Barrangou, 2016, Applications of CRISPR technologies in research and beyond, Nat. Biotechnol., 34, 933, 10.1038/nbt.3659 · DOI · Paper page
- Barrera, 2020, CRISPR/Cas: From adaptive immune system in prokaryotes to therapeutic weapon against immune-related diseases, Int. Rev. Immunol., 39, 11, 10.1080/08830185.2019.1677645 · DOI
- Gersbach, 2019, The next generation of CRISPR-Cas technologies and applications, Nat. Rev. Mol. Cell Biol., 20, 490, 10.1038/s41580-019-0131-5 · DOI · Paper page
- Terns, 2018, CRISPR-based technologies: Impact of RNA-targeting systems, Mol. Cell, 72, 404, 10.1016/j.molcel.2018.09.018 · DOI · Paper page
- Gupta, 2019, CRISPR-Cas9 system: A new-fangled dawn in gene editing, Life Sci., 232, 116636, 10.1016/j.lfs.2019.116636 · DOI
- Mojica, 2009, Short motif sequences determine the targets of the prokaryotic CRISPR defence system, Microbiology, 155 Pt 3, 733, 10.1099/mic.0.023960-0 · DOI · Paper page
- Jiang, 2016, Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage, Science, 351, 867, 10.1126/science.aad8282 · DOI
- Peng, 2014, Making designer mutants in model organisms, Development, 141, 4042, 10.1242/dev.102186 · DOI
- Chang, 2017, Non-homologous DNA end joining and alternative pathways to double-strand break repair, Nat. Rev. Mol. Cell Biol., 18, 495, 10.1038/nrm.2017.48 · DOI · Paper page
- Salsman, 2017, Precision genome editing in the CRISPR era, Biochem. Cell Biol., 95, 187, 10.1139/bcb-2016-0137 · DOI
- Dumitrache, 2011, Trex2 enables spontaneous sister chromatid exchanges without facilitating DNA double-strand break repair, Genetics, 188, 787, 10.1534/genetics.111.129833 · DOI
- Blackford, 2017, ATM, ATR, and DNA-PK: The trinity at the heart of the DNA damage response, Mol. Cell, 66, 801, 10.1016/j.molcel.2017.05.015 · DOI
- Schwertman, 2016, Regulation of DNA double-strand break repair by ubiquitin and ubiquitin-like modifiers, Nat. Rev. Mol. Cell Biol., 17, 379, 10.1038/nrm.2016.58 · DOI
- Nowsheen, 2018, L3MBTL2 orchestrates ubiquitin signalling by dictating the sequential recruitment of RNF8 and RNF168 after DNA damage, Nat. Cell Biol., 20, 455, 10.1038/s41556-018-0071-x · DOI
- Symington, 2016, Mechanism and regulation of DNA end resection in eukaryotes, Crit. Rev. Biochem. Mol. Biol., 51, 195, 10.3109/10409238.2016.1172552 · DOI
- Symington, 2011, Double-strand break end resection and repair pathway choice, Annu Rev. Genet., 45, 247, 10.1146/annurev-genet-110410-132435 · DOI
- Huertas, 2009, Human CtIP mediates cell cycle control of DNA end resection and double strand break repair, J. Biol. Chem., 284, 9558, 10.1074/jbc.M808906200 · DOI
- Garcia, 2011, Bidirectional resection of DNA double-strand breaks by Mre11 and Exo1, Nature, 479, 241, 10.1038/nature10515 · DOI
- Daley, 2017, Enhancement of BLM-DNA2-mediated long-range DNA end resection by CtIP, Cell Rep., 21, 324, 10.1016/j.celrep.2017.09.048 · DOI
- Renkawitz, 2014, Mechanisms and principles of homology search during recombination, Nat. Rev. Mol. Cell Biol., 15, 369, 10.1038/nrm3805 · DOI
- Bhat, 2018, RPA and RAD51: Fork reversal, fork protection, and genome stability, Nat. Struct. Mol. Biol., 25, 446, 10.1038/s41594-018-0075-z · DOI
- Sung, 2008, Mechanism of eukaryotic homologous recombination, Annu. Rev. Biochem., 77, 229, 10.1146/annurev.biochem.77.061306.125255 · DOI
- West, 2009, The search for a human Holliday junction resolvase, Biochem. Soc. Trans., 37, 519, 10.1042/BST0370519 · DOI
- Fell, 2015, The Ku heterodimer: Function in DNA repair and beyond, Mutat. Res. Rev. Mutat. Res., 763, 15, 10.1016/j.mrrev.2014.06.002 · DOI
- Kragelund, 2016, The Ku70/80 ring in Non-Homologous End-Joining: Easy to slip on, hard to remove, Front. Biosci., 21, 514, 10.2741/4406 · DOI
- Davis, 2014, DNA-PK: A dynamic enzyme in a versatile DSB repair pathway, DNA Repair, 17, 21, 10.1016/j.dnarep.2014.02.020 · DOI
- Conlin, 2017, DNA ligase IV guides end-processing choice during nonhomologous end joining, Cell Rep., 20, 2810, 10.1016/j.celrep.2017.08.091 · DOI
- Stinson, 2020, A mechanism to minimize errors during non-homologous end joining, Mol. Cell, 77, 1080, 10.1016/j.molcel.2019.11.018 · DOI
- Truong, 2013, Microhomology-mediated end joining and homologous recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells, Proc. Natl. Acad. Sci. USA, 110, 7720, 10.1073/pnas.1213431110 · DOI
- Wang, 2017, Microhomology-mediated end joining: New players join the team, Cell Biosci., 7, 6, 10.1186/s13578-017-0136-8 · DOI
- Cheng, 2011, Ku counteracts mobilization of PARP1 and MRN in chromatin damaged with DNA double-strand breaks, Nucleic Acids Res., 39, 9605, 10.1093/nar/gkr656 · DOI
- Gong, 2015, Mammalian polymerase theta promotes alternative NHEJ and suppresses recombination, Nature, 518, 254, 10.1038/nature14157 · DOI
- Wang, 2006, PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways, Nucleic Acids Res., 34, 6170, 10.1093/nar/gkl840 · DOI
- Sfeir, 2015, Microhomology-mediated end joining: A back-up survival mechanism or dedicated pathway?, Trends Biochem. Sci., 40, 701, 10.1016/j.tibs.2015.08.006 · DOI · Paper page
- Nakade, 2014, Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9, Nat. Commun., 5, 5560, 10.1038/ncomms6560 · DOI
- Sakuma, 2016, MMEJ-assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems, Nat. Protoc., 11, 118, 10.1038/nprot.2015.140 · DOI
- Lee, 2018, CRISPR and target-specific DNA endonucleases for efficient DNA Knock-in in eukaryotic genomes, Mol. Cells, 41, 943
- Bhargava, 2016, Regulation of single-strand annealing and its role in genome maintenance, Trends Genet., 32, 566, 10.1016/j.tig.2016.06.007 · DOI
- Sonoda, 1998, Homologous recombination, but not DNA repair, is reduced in vertebrate cells deficient in RAD52, Mol. Cell Biol., 18, 6430, 10.1128/MCB.18.11.6430 · DOI
- Stone, 2014, DNA damage emergency: Cellular garbage disposal to the rescue?, Oncogene, 33, 805, 10.1038/onc.2013.60 · DOI
- Huertas, 2010, DNA resection in eukaryotes: Deciding how to fix the break, Nat. Struct. Mol. Biol., 17, 11, 10.1038/nsmb.1710 · DOI
- Hochegger, 2008, Cyclin-dependent kinases and cell-cycle transitions: Does one fit all?, Nat. Rev. Mol. Cell Biol., 9, 910, 10.1038/nrm2510 · DOI
- Buis, 2012, Mre11 regulates CtIP-dependent double-strand break repair by interaction with CDK2, Nat. Struct. Mol. Biol., 19, 246, 10.1038/nsmb.2212 · DOI
- Yu, 1998, The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression, J. Biol. Chem., 273, 25388, 10.1074/jbc.273.39.25388 · DOI
- Tomimatsu, 2014, Phosphorylation of EXO1 by CDKs 1 and 2 regulates DNA end resection and repair pathway choice, Nat. Commun., 5, 3561, 10.1038/ncomms4561 · DOI
- Tkac, 2016, HELB Is a feedback inhibitor of DNA end resection, Mol. Cell, 61, 405, 10.1016/j.molcel.2015.12.013 · DOI
- Lu, 2016, RECQL4 Promotes DNA end resection in repair of DNA double-strand breaks, Cell Rep., 16, 161, 10.1016/j.celrep.2016.05.079 · DOI
- Lu, 2017, Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair, Nat. Commun., 8, 2039, 10.1038/s41467-017-02146-3 · DOI
- Uckelmann, 2017, Histone ubiquitination in the DNA damage response, DNA Repair, 56, 92, 10.1016/j.dnarep.2017.06.011 · DOI
- Chapman, 2012, Playing the end game: DNA double-strand break repair pathway choice, Mol. Cell, 47, 497, 10.1016/j.molcel.2012.07.029 · DOI
- Ismail, 2015, The RNF138 E3 ligase displaces Ku to promote DNA end resection and regulate DNA repair pathway choice, Nat. Cell Biol., 17, 1446, 10.1038/ncb3259 · DOI
- Brown, 2015, Neddylation promotes ubiquitylation and release of Ku from DNA-damage sites, Cell Rep., 11, 704, 10.1016/j.celrep.2015.03.058 · DOI
- Feng, 2012, The E3 ligase RNF8 regulates KU80 removal and NHEJ repair, Nat. Struct. Mol. Biol., 19, 201, 10.1038/nsmb.2211 · DOI
- Himmels, 2016, Controlling DNA-end resection: An emerging task for ubiquitin and SUMO, Front. Genet., 7, 152, 10.3389/fgene.2016.00152 · DOI
- Lafranchi, 2014, APC/C(Cdh1) controls CtIP stability during the cell cycle and in response to DNA damage, EMBO J., 33, 2860, 10.15252/embj.201489017 · DOI
- Steger, 2013, Prolyl isomerase PIN1 regulates DNA double-strand break repair by counteracting DNA end resection, Mol. Cell, 50, 333, 10.1016/j.molcel.2013.03.023 · DOI
- Kakarougkas, 2014, DNA DSB repair pathway choice: An orchestrated handover mechanism, Br. J. Radiol., 87, 20130685, 10.1259/bjr.20130685 · DOI
- Mirman, 2020, 53BP1: A DSB escort, Genes Dev., 34, 7, 10.1101/gad.333237.119 · DOI
- Panier, 2014, Double-strand break repair: 53BP1 comes into focus, Nat. Rev. Mol. Cell Biol., 15, 7, 10.1038/nrm3719 · DOI
- Orthwein, 2013, A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice, Mol. Cell, 49, 872, 10.1016/j.molcel.2013.01.001 · DOI
- Noordermeer, 2018, The shieldin complex mediates 53BP1-dependent DNA repair, Nature, 560, 117, 10.1038/s41586-018-0340-7 · DOI
- Setiaputra, 2019, Shieldin—The protector of DNA ends, EMBO Rep., 20, e47560, 10.15252/embr.201847560 · DOI
- Wang, 2014, PTIP associates with Artemis to dictate DNA repair pathway choice, Genes Dev., 28, 2693, 10.1101/gad.252478.114 · DOI
- Mohammadzadeh, 2019, 53BP1: A key player of DNA damage response with critical functions in cancer, DNA Repair, 73, 110, 10.1016/j.dnarep.2018.11.008 · DOI
- Huertas, 2014, BRCA1 accelerates CtIP-mediated DNA-end resection, Cell Rep., 9, 451, 10.1016/j.celrep.2014.08.076 · DOI
- Zhang, 2016, A cell cycle-dependent BRCA1-UHRF1 cascade regulates DNA double-strand break repair pathway choice, Nat. Commun., 7, 10201, 10.1038/ncomms10201 · DOI
- Densham, 2016, Human BRCA1-BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection, Nat. Struct. Mol. Biol., 23, 647, 10.1038/nsmb.3236 · DOI
- Isono, 2017, BRCA1 directs the repair pathway to homologous recombination by promoting 53BP1 dephosphorylation, Cell Rep., 18, 520, 10.1016/j.celrep.2016.12.042 · DOI
- Vartak, 2015, Inhibition of nonhomologous end joining to increase the specificity of CRISPR/Cas9 genome editing, FEBS J., 282, 4289, 10.1111/febs.13416 · DOI
- Beumer, 2013, Donor DNA utilization during gene targeting with zinc-finger nucleases, G3, 3, 657, 10.1534/g3.112.005439 · DOI
- Singh, 2015, A mouse geneticist’s practical guide to CRISPR applications, Genetics, 199, 1, 10.1534/genetics.114.169771 · DOI
- Chu, 2015, Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells, Nat. Biotechnol., 33, 543, 10.1038/nbt.3198 · DOI · Paper page
- Zhang, 2018, An efficient platform for generating somatic point mutations with germline transmission in the zebrafish by CRISPR/Cas9-mediated gene editing, J. Biol. Chem., 293, 6611, 10.1074/jbc.RA117.001080 · DOI
- Ma, 2016, Increasing the efficiency of CRISPR/Cas9-mediated precise genome editing in rats by inhibiting NHEJ and using Cas9 protein, RNA Biol., 13, 605, 10.1080/15476286.2016.1185591 · DOI
- Hu, 2018, Ligase IV inhibitor SCR7 enhances gene editing directed by CRISPR-Cas9 and ssODN in human cancer cells, Cell Biosci., 8, 12, 10.1186/s13578-018-0200-z · DOI
- Li, 2017, Small molecules enhance CRISPR/Cas9-mediated homology-directed genome editing in primary cells, Sci. Rep., 7, 8943, 10.1038/s41598-017-09306-x · DOI
- Song, 2016, RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency, Nat. Commun., 7, 10548, 10.1038/ncomms10548 · DOI
- Gutschner, 2016, Post-translational Regulation of Cas9 during G1 enhances homology-directed repair, Cell Rep., 14, 1555, 10.1016/j.celrep.2016.01.019 · DOI
- Xie, 2017, Optimization of a CRISPR/Cas9-mediated Knock-in Strategy at the Porcine Rosa26 locus in porcine foetal fibroblasts, Sci. Rep., 7, 3036, 10.1038/s41598-017-02785-y · DOI
- Jayavaradhan, 2019, A versatile tool for the quantification of CRISPR/Cas9-induced genome editing events in human hematopoietic cell lines and hematopoietic stem/progenitor cells, J. Mol. Biol., 431, 102, 10.1016/j.jmb.2018.05.005 · DOI
- Canny, 2018, Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency, Nat. Biotechnol., 36, 95, 10.1038/nbt.4021 · DOI
- Aird, 2018, Increasing Cas9-mediated homology-directed repair efficiency through covalent tethering of DNA repair template, Commun. Biol., 1, 54, 10.1038/s42003-018-0054-2 · DOI
- Greco, 2016, SCR7 is neither a selective nor a potent inhibitor of human DNA ligase IV, DNA Repair., 43, 18, 10.1016/j.dnarep.2016.04.004 · DOI
- Li, 2018, Suppressing Ku70/Ku80 expression elevates homology-directed repair efficiency in primary fibroblasts, Int. J. Biochem. Cell Biol., 99, 154, 10.1016/j.biocel.2018.04.011 · DOI
- Robert, 2015, Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing, Genome Med., 7, 93, 10.1186/s13073-015-0215-6 · DOI
- Aksoy, 2019, Chemical reprogramming enhances homology-directed genome editing in zebrafish embryos, Commun. Biol., 2, 198, 10.1038/s42003-019-0444-0 · DOI
- Riesenberg, 2018, Targeting repair pathways with small molecules increases precise genome editing in pluripotent stem cells, Nat. Commun., 9, 2164, 10.1038/s41467-018-04609-7 · DOI · Paper page
- Riesenberg, 2019, Simultaneous precise editing of multiple genes in human cells, Nucleic Acids Res., 47, e116, 10.1093/nar/gkz669 · DOI
- Frank, 1998, Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV, Nature, 396, 173, 10.1038/24172 · DOI
- Jayathilaka, 2008, A chemical compound that stimulates the human homologous recombination protein RAD51, Proc. Natl. Acad. Sci. USA, 105, 15848, 10.1073/pnas.0808046105 · DOI
- Pinder, 2015, Nuclear domain ’knock-in’ screen for the evaluation and identification of small molecule enhancers of CRISPR-based genome editing, Nucleic Acids Res., 43, 9379, 10.1093/nar/gkv993 · DOI
- Kurihara, 2020, DNA repair protein RAD51 enhances the CRISPR/Cas9-mediated knock-in efficiency in brain neurons, Biochem. Biophys. Res. Commun., 524, 621, 10.1016/j.bbrc.2020.01.132 · DOI
- Haber, 1995, In vivo biochemistry: Physical monitoring of recombination induced by site-specific endonucleases, Bioessays, 17, 609, 10.1002/bies.950170707 · DOI
- Lok, 2012, Molecular pathways: Understanding the role of Rad52 in homologous recombination for therapeutic advancement, Clin. Cancer Res., 18, 6400, 10.1158/1078-0432.CCR-11-3150 · DOI
- Galli, 2005, Potentiation of gene targeting in human cells by expression of Saccharomyces cerevisiae Rad52, Nucleic Acids Res., 33, 4639, 10.1093/nar/gki778 · DOI
- Shao, 2017, Enhancing CRISPR/Cas9-mediated homology-directed repair in mammalian cells by expressing Saccharomyces cerevisiae Rad52, Int. J. Biochem. Cell Biol., 92, 43, 10.1016/j.biocel.2017.09.012 · DOI
- Wang, L., Yang, L., Guo, Y., Du, W., Yin, Y., Zhang, T., and Lu, H. (2017). Enhancing targeted genomic DNA editing in chicken cells using the CRISPR/Cas9 system. PLoS ONE, 12. · DOI
- Paulsen, 2017, Ectopic expression of RAD52 and dn53BP1 improves homology-directed repair during CRISPR-Cas9 genome editing, Nat. Biomed. Eng., 1, 878, 10.1038/s41551-017-0145-2 · DOI
- Charpentier, 2018, CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair, Nat. Commun., 9, 1133, 10.1038/s41467-018-03475-7 · DOI
- Tran, 2019, Enhancement of precise gene editing by the association of Cas9 With homologous recombination factors, Front. Genet., 10, 365, 10.3389/fgene.2019.00365 · DOI
- Reuven, N., Adler, J., Broennimann, K., Myers, N., and Shaul, Y. (2019). Recruitment of DNA repair MRN complex by intrinsically disordered protein domain fused to Cas9 improves efficiency of CRISPR-mediated genome editing. Biomolecules, 9. · DOI
- Yu, 2015, Small molecules enhance CRISPR genome editing in pluripotent stem cells, Cell Stem Cell, 16, 142, 10.1016/j.stem.2015.01.003 · DOI · Paper page
- Xie, 2007, Distinct roles of chromatin-associated proteins MDC1 and 53BP1 in mammalian double-strand break repair, Mol. Cell, 28, 1045, 10.1016/j.molcel.2007.12.005 · DOI
- Jayavaradhan, 2019, CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites, Nat. Commun., 10, 2866, 10.1038/s41467-019-10735-7 · DOI
- Nambiar, 2019, Stimulation of CRISPR-mediated homology-directed repair by an engineered RAD18 variant, Nat. Commun., 10, 3395, 10.1038/s41467-019-11105-z · DOI
- Lin, 2014, Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery, Elife, 3, e04766, 10.7554/eLife.04766 · DOI · Paper page
- Yang, 2016, Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases, Sci. Rep., 6, 21264, 10.1038/srep21264 · DOI
- Lomova, 2019, Improving gene editing outcomes in human hematopoietic stem and progenitor cells by temporal control of DNA repair, Stem Cells, 37, 284, 10.1002/stem.2935 · DOI
- Wienert, 2020, Timed inhibition of CDC7 increases CRISPR-Cas9 mediated templated repair, Nat. Commun., 11, 2109, 10.1038/s41467-020-15845-1 · DOI
- Gerlach, M., Kraft, T., Brenner, B., Petersen, B., Niemann, H., and Montag, J. (2018). Efficient Knock-in of a Point Mutation in Porcine Fibroblasts Using the CRISPR/Cas9-GMNN Fusion Gene. Genes, 9. · DOI
- Howden, 2016, A Cas9 variant for efficient generation of indel-free knockin or gene-corrected human pluripotent stem cells, Stem Cell Rep., 7, 508, 10.1016/j.stemcr.2016.07.001 · DOI
- Ye, 2018, Programmable DNA repair with CRISPRa/i enhanced homology-directed repair efficiency with a single Cas9, Cell Discov., 4, 46, 10.1038/s41421-018-0049-7 · DOI
- Devkota, 2018, The road less traveled: Strategies to enhance the frequency of homology-directed repair (HDR) for increased efficiency of CRISPR/Cas-mediated transgenesis, BMB Rep., 51, 437, 10.5483/BMBRep.2018.51.9.187 · DOI
- Abdeen, 2017, Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editing, Nat. Commun., 8, 1711, 10.1038/s41467-017-01875-9 · DOI · Paper page
- Ma, 2017, Efficient generation of mice carrying homozygous double-floxp alleles using the Cas9-Avidin/Biotin-donor DNA system, Cell Res., 27, 578, 10.1038/cr.2017.29 · DOI
- Savic, 2018, Covalent linkage of the DNA repair template to the CRISPR-Cas9 nuclease enhances homology-directed repair, Elife, 7, e33761, 10.7554/eLife.33761 · DOI
- Liang, 2017, Enhanced CRISPR/Cas9-mediated precise genome editing by improved design and delivery of gRNA, Cas9 nuclease, and donor DNA, J. Biotechnol., 241, 136, 10.1016/j.jbiotec.2016.11.011 · DOI
- Richardson, 2016, Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA, Nat. Biotechnol., 34, 339, 10.1038/nbt.3481 · DOI · Paper page
- Song, 2017, Optimizing the DNA Donor Template for Homology-Directed Repair of Double-Strand Breaks, Mol. Ther Nucleic Acids, 7, 53, 10.1016/j.omtn.2017.02.006 · DOI
- Suzuki, 2016, In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration, Nature, 540, 144, 10.1038/nature20565 · DOI · Paper page
- Zhang, 2017, Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage, Genome Biol., 18, 35, 10.1186/s13059-017-1164-8 · DOI
Cited by
Sorted by citations
Past, present, and future of CRISPR genome editing technologies
Pacesa, M., Pelea, O., & Jinek, M. (2024) · Cell · doi:10.1016/j.cell.2024.01.042 · Cited by 609
Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing
Mengstie, M. A., & Wondimu, B. Z. (2021) · Biologics: Targets and Therapy · doi:10.2147/btt.s326422 · Cited by 478
Siles, L., & Pomares, E. (2025) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2025.102482 · Cited by 4
Metadata
- Authors
- Yang, H., Ren, S., Yu, S., Pan, H., Li, T., Ge, S., Zhang, J., & Xia, N.
- Affiliations
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Disease, Collaborative Innovation Centers of Biological Products, School of Public Health, Xiamen University, Xiamen 361102, China
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-09-04
- Volume
- 21
- Issue
- 18
- Pages
- 6461
- ISSN
- 1422-0067
- PMC
- PMC7555059
- Cited by
- 237
- References
- 8
- Language
- en
- Funders
- National Natural Science Foundation of China (31971369)
- National Key Program for Infectious Disease of China (2018ZX10732401-003-008)
- Natural Science Foundation of Fujian Province of China (Natural Science Foundation of Fujian Province of China)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review